Humans

Recurrence of chronic active Epstein-Barr virus infection from donor cells after achieving complete response through allogeneic bone marrow transplantation.

Arai A, Imadome K-, Wang L, Wu N, Kurosu T, Wake A, et al. Recurrence of chronic active Epstein-Barr virus infection from donor cells after achieving complete response through allogeneic bone marrow transplantation. Internal medicine (Tokyo, Japan)// // Intern Med. 2012;51(7):777-82.

Reactivation of hepatitis B virus with mutated hepatitis B surface antigen in a liver transplant recipient receiving a graft from an antibody to hepatitis B surface antigen- and antibody to hepatitis B core antigen-positive donor.

Blaich A, Manz M, Dumoulin A, Schuttler CG, Hirsch HH, Gerlich WH, et al. Reactivation of hepatitis B virus with mutated hepatitis B surface antigen in a liver transplant recipient receiving a graft from an antibody to hepatitis B surface antigen- and antibody to hepatitis B core antigen-positive donor. Transfusion// // Transfusion. 2012;52(9):1999-2006.

Rabies in a blind patient: confusion after corneal transplantation.

Masthi NR, Raviprakash D, Gangasagara SB, Sriprakash KS, Ashwin BY, Ullas PT, et al. Rabies in a blind patient: confusion after corneal transplantation. The National medical journal of India// // Natl Med J India. 2012;25(2):83-4.

Rabies after corneal transplantation: non-canine rabies and eye banking.

Bhaumik S. Rabies after corneal transplantation: non-canine rabies and eye banking. The National medical journal of India// // Natl Med J India. 2012;25(4):249-50.

West Nile virus lineage 2 infection in a blood donor from Vienna, Austria, August 2014.

Jungbauer C, Hourfar MK, Stiasny K, Aberle SW, Cadar D, Schmidt-Chanasit J, et al. West Nile virus lineage 2 infection in a blood donor from Vienna, Austria, August 2014. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology// J Clin Virol. 2015;64:16-9.

Impact of Epstein-Barr virus donor and recipient serostatus on the incidence of post-transplant lymphoproliferative disorder in kidney transplant recipients.

Sampaio MS, Cho YW, Shah T, Bunnapradist S, Hutchinson IV. Impact of Epstein-Barr virus donor and recipient serostatus on the incidence of post-transplant lymphoproliferative disorder in kidney transplant recipients. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association// Nephrol Dial Transplant. 2012;27(7):2971-9.

Human T lymphotropic virus type-1-associated myelopathy manifesting shortly after living-donor renal transplantation.

Nagamine Y, Hayashi T, Kato Y, Horiuchi Y, Tanahashi N. Human T lymphotropic virus type-1-associated myelopathy manifesting shortly after living-donor renal transplantation. Internal medicine (Tokyo, Japan)// Intern Med. 2015;54(1):75-8.

HTLV-1 in solid-organ transplantation: current challenges and future management strategies.

Armstrong MJ, Corbett C, Rowe IA, Taylor GP, Neuberger JM. HTLV-1 in solid-organ transplantation: current challenges and future management strategies. Transplantation// Transplantation. 2012;94(11):1075-84.

Herpes simplex hepatitis after liver transplantation: case report and literature review.

Cote-Daigneault J, Carrier FM, Toledano K, Wartelle-Bladu C, Willems B. Herpes simplex hepatitis after liver transplantation: case report and literature review. Transplant infectious disease : an official journal of the Transplantation Society// Transpl Infect Dis. 2014;16(1):130-4.

Hepatitis C transmission from viremic donors in hematopoietic stem cell transplant.

Hsiao H-, Liu Y-, Wang H-, Wu C-, Cho S-, Hsu J-, et al. Hepatitis C transmission from viremic donors in hematopoietic stem cell transplant. Transplant infectious disease : an official journal of the Transplantation Society// Transpl Infect Dis. 2014;16(6):1003-6.

Pages